Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Past hour
    • Any time
    • Past 24 hours
    • Past 7 days
    • Past 30 days

News

Pharmabiz
20m
US FDA grants priority review status to Johnson & Johnson’s TAR-200 NDA in high-risk non-muscle invasive bladder cancer
Raritan, New Jersey Friday, July 18, 2025, 15:00 Hrs [IST] ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

House passes spending cuts
CBS to end 'The Late Show'
Diagnosed with cancer
Band cancels entire tour
Dies in paragliding crash
NFL's highest-paid defender
Dies trying to save swimmers
Deodorant recalled
Teen arrested in murder
Judge OKs release plan
Sentenced to 30 days in jail
Hands over Medicaid data
Diagnosed w/ vein condition
Former NFL LB Braman dies
Gets FDA authorization
Chicken sausage recalled
10th person dies from fire
Gulf Coast flood threat
Pulls out of All-Star weekend
Weekly jobless claims fall
Lost mother, son rescued
House passes stablecoin bill
Bove clears Senate panel
5 charged in murder case
Suspended over doping test
Suspends China travel
Idaho judge lifts gag order
Retail sales rebound
To lower voting age to 16
DOJ seeks one-day sentence
Unveils ChatGPT agent
Iraq mall fire kills dozens
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy